Nitrosamine impurities are highly potent, carcinogenic substances that can form when nitrosating agents react with amines during production, storage, or degradation. These include both volatile and non-volatile nitroso compounds, many of which, such as NDMA, are known or suspected human carcinogens. Due to their mutagenic potential, they are strictly regulated, with exposure limits set in the nanogram-per-day range, requiring rigorous risk assessment, analytical testing, and control strategies to ensure safety in pharmaceuticals, foods, and the environment.
Our portfolio offers a broad selection of highly regulated nitrosamines, including NDMA, NDEA, NDPA, and NDBA, along with an extensive range of nitrosamine impurity reference standards. These resources support accurate analysis, quality control, and regulatory compliance, helping researchers and manufacturers effectively monitor and manage nitrosamine-related risks.
Manasa Life Sciences is a global manufacturer and supplier of top-quality nitrosamine impurities, delivering dependable solutions for research applications and regulatory testing. We are strongly committed to responsibility and quality, and we provide complete documentation along with reliable research and testing support.